ZVRA Q2 2020 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$559M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M

Gross Profit

$6M90.7% margin

Operating Income

$3M37.5% margin

Net Income

$859,00012.4% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

+230.7%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$620,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$75M

Stockholders' Equity

-$63M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$0	—
Gross Profit	$6M	$0	—
Operating Income	$3M	-$8M	+133.3%
Net Income	$859,000	-$9M	+109.3%